福泰制药Vertex Pharmaceuticals Inc. (VRTX) 2003年10-K年度报告「NASDAQ」.pdf

1、FORM 10-K VERTEX PHARMACEUTICALS INC/MA(Annual Report)Filed 3/15/2004 For Period Ending 12/31/2003Address130 WAVERLY STREETCAMBRIDGE,Massachusetts 02139-4242Telephone616-577-6000 CIK0000875320IndustryBiotechnology&DrugsSectorHealthcareFiscal Year12/31 QuickLinks-Click here to rapidly navigate throug

2、h this document UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON,D.C.20549 FORM 10-K Commission file number 000-19319 Vertex Pharmaceuticals Incorporated (Exact name of registrant as specified in its charter)(617)444-6100 (Registrants telephone number,including area code)Securities regist

3、ered pursuant to Section 12(b)of the Exchange Act:None Securities registered pursuant to Section 12(g)of the Exchange Act:Common Stock,$0.01 Par Value Per Share (Title of class)(Mark One)?ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended De

4、cember 31,2003 or?TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Massachusetts 04-3039129(State of incorporation)(I.R.S.Employer Identification No.)130 Waverly Street Cambridge,Massachusetts 02139-4242(Address of principal ex

5、ecutive offices)(Zip Code)Indicate by check mark whether the registrant:(1)has filed all reports required to be filed by Section 13 or 15(d)of the Securities Exchange Act of 1934 during the preceding 12 months(or for such shorter period that the registrant was required to file such reports),and(2)ha

6、s been subject to such filing requirements for the past 90 days.Yes X No Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K is not contained herein,and will not be contained,to the best of the registrants knowledge,in definitive proxy or information stat